Yellow Fever Outbreak in Eastern Senegal, 2020-2021.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
28 07 2021
Historique:
received: 03 07 2021
revised: 23 07 2021
accepted: 24 07 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 9 2 2022
Statut: epublish

Résumé

Yellow fever virus remains a major threat in low resource countries in South America and Africa despite the existence of an effective vaccine. In Senegal and particularly in the eastern part of the country, periodic sylvatic circulation has been demonstrated with varying degrees of impact on populations in perpetual renewal. We report an outbreak that occurred from October 2020 to February 2021 in eastern Senegal, notified and managed through the synergistic effort yellow fever national surveillance implemented by the Senegalese Ministry of Health in collaboration with the World Health Organization, the countrywide 4S network set up by the Ministry of Health, the Institut Pasteur de Dakar, and the surveillance of arboviruses and hemorrhagic fever viruses in human and vector populations implemented since mid 2020 in eastern Senegal. Virological analyses highlighted the implication of sylvatic mosquito species in virus transmission. Genomic analysis showed a close relationship between the circulating strain in eastern Senegal, 2020, and another one from the West African lineage previously detected and sequenced two years ago from an unvaccinated Dutch traveler who visited the Gambia and Senegal before developing signs after returning to Europe. Moreover, genome analysis identified a 6-nucleotide deletion in the variable domain of the 3'UTR with potential impact on the biology of the viral strain that merits further investigations. Integrated surveillance of yellow fever virus but also of other arboviruses of public health interest is crucial in an ecosystem such as eastern Senegal.

Identifiants

pubmed: 34452343
pii: v13081475
doi: 10.3390/v13081475
pmc: PMC8402698
pii:
doi:

Substances chimiques

Viral Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI151801
Pays : United States
Organisme : NIH HHS
ID : 1U01AI151801-01
Pays : United States

Références

Open Forum Infect Dis. 2017 Dec 02;5(1):ofx259
pubmed: 29354659
Am J Trop Med Hyg. 2015 Jan;92(1):88-97
pubmed: 25404071
Am J Trop Med Hyg. 2014 Jun;90(6):1003-13
pubmed: 24615140
Am J Trop Med Hyg. 1998 Jul;59(1):108-14
pubmed: 9684637
Bioinformatics. 2019 Mar 1;35(5):871-873
pubmed: 30124794
J Clin Virol. 2015 Mar;64:160-73
pubmed: 25453327
Antiviral Res. 2018 Nov;159:13-25
pubmed: 30217649
J Virol. 2010 Jan;84(2):765-72
pubmed: 19889759
Virus Res. 1999 Nov;64(2):107-23
pubmed: 10518708
JAMA. 2008 Aug 27;300(8):960-2
pubmed: 18728272
J Med Entomol. 1994 Jul;31(4):623-7
pubmed: 7932611
Trans R Soc Trop Med Hyg. 2014 Aug;108(8):482-7
pubmed: 24980556
J Gen Virol. 2014 Apr;95(Pt 4):823-835
pubmed: 24394696
J Virol. 1998 Mar;72(3):2132-40
pubmed: 9499069
Lancet Glob Health. 2018 Mar;6(3):e270-e278
pubmed: 29398634
Int J Mol Sci. 2021 Apr 03;22(7):
pubmed: 33916729
BMC Infect Dis. 2021 Jan 7;21(1):31
pubmed: 33413174
Nat Med. 2017 Jun;23(6):763-767
pubmed: 28394328
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Science. 1985 Aug 23;229(4715):726-33
pubmed: 4023707
Nucleic Acids Res. 2017 Jan 9;45(1):67-80
pubmed: 27899609
Euro Surveill. 2019 Jan;24(4):
pubmed: 30696531
Res Virol. 1992 Nov-Dec;143(6):417-22
pubmed: 1297177
PLoS Negl Trop Dis. 2012;6(6):e1649
pubmed: 22720097
Trends Microbiol. 2018 Nov;26(11):913-928
pubmed: 29933925
Viruses. 2017 Jun 06;9(6):
pubmed: 28587300
Emerg Infect Dis. 2003 Mar;9(3):362-7
pubmed: 12643833
Trop Dis Travel Med Vaccines. 2020 Jan 10;6:1
pubmed: 31938550
J Clin Virol. 2005 Aug;33(4):274-80
pubmed: 16036176
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Clin Infect Dis. 2002 Nov 15;35(10):e113-6
pubmed: 12410495
Virology. 1990 Jul;177(1):159-74
pubmed: 2353452
Malar J. 2016 Jan 28;15:47
pubmed: 26821709
BMC Microbiol. 2020 Jun 26;20(1):181
pubmed: 32590939
J Clin Virol. 2010 Jul;48(3):187-92
pubmed: 20556888
BMC Infect Dis. 2018 Dec 12;18(1):642
pubmed: 30541472
J Med Entomol. 1996 Sep;33(5):760-5
pubmed: 8840681

Auteurs

Moussa Moïse Diagne (MM)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Marie Henriette Dior Ndione (MHD)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Alioune Gaye (A)

Zoology Medical Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Mamadou Aliou Barry (MA)

Epidemiology, Clinical Research and Data Science Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Diawo Diallo (D)

Zoology Medical Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Amadou Diallo (A)

Epidemiology, Clinical Research and Data Science Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Lusajo L Mwakibete (LL)

Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.

Mamadou Diop (M)

Epidemiology, Clinical Research and Data Science Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

El Hadji Ndiaye (EH)

Zoology Medical Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Vida Ahyong (V)

Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.

Babacar Diouf (B)

Zoology Medical Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Moufid Mhamadi (M)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Cheikh Tidiane Diagne (CT)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Fodé Danfakha (F)

Kedougou Medical Region, Ministry of Health, Kedougou 26005, Senegal.

Boly Diop (B)

Prevention Department, Ministry of Health, Dakar 220, Senegal.

Oumar Faye (O)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Cheikh Loucoubar (C)

Epidemiology, Clinical Research and Data Science Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Gamou Fall (G)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Cristina M Tato (CM)

Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.

Amadou Alpha Sall (AA)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Scott C Weaver (SC)

World Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Mawlouth Diallo (M)

Zoology Medical Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Ousmane Faye (O)

Virology Department, Institut Pasteur de Dakar, Dakar 220, Senegal.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH